GAM Holding AG - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
GAM Holding AG ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2021$1,983,000
-24.5%
70,7000.0%0.09%
-41.8%
Q3 2020$2,628,000
-27.6%
70,7000.0%0.16%
-30.1%
Q2 2020$3,628,000
+62.8%
70,7000.0%0.23%
+49.7%
Q1 2020$2,229,000
-57.5%
70,700
-19.7%
0.15%
-39.1%
Q4 2019$5,247,000
+62.6%
88,0000.0%0.25%
+74.6%
Q3 2019$3,226,000
-21.2%
88,0000.0%0.14%
-11.2%
Q2 2019$4,094,000
+15.9%
88,0000.0%0.16%
+8.1%
Q1 2019$3,533,000
-12.7%
88,0000.0%0.15%
-27.8%
Q4 2018$4,048,000
-31.8%
88,000
-34.2%
0.20%
-5.1%
Q3 2018$5,937,000
+13.2%
133,8000.0%0.22%
+18.7%
Q2 2018$5,244,000
-63.5%
133,800
-32.6%
0.18%
-64.1%
Q1 2018$14,365,000
-3.0%
198,600
-11.7%
0.51%
+11.7%
Q4 2017$14,814,000
+31.4%
225,0000.0%0.45%
-4.6%
Q3 2017$11,277,000
+8.3%
225,0000.0%0.48%
+209.1%
Q2 2017$10,413,000
+31.1%
225,0000.0%0.15%
+22.2%
Q1 2017$7,945,000
+891.9%
225,000
+251.6%
0.13%
+800.0%
Q4 2016$801,000
-9.6%
64,0000.0%0.01%
-12.5%
Q3 2016$886,000
-30.0%
64,000
-50.0%
0.02%
-20.0%
Q2 2016$1,265,000
+16.9%
128,000
+100.0%
0.02%
+11.1%
Q1 2016$1,082,000
-24.1%
64,0000.0%0.02%
-18.2%
Q4 2015$1,425,000
-5.6%
64,0000.0%0.02%
-15.4%
Q3 2015$1,510,000
-57.6%
64,000
+46.8%
0.03%
-50.0%
Q2 2015$3,565,00043,6000.05%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$69,675,00019.39%
Endurant Capital Management LP 207,293$5,390,0001.94%
Bellevue Group AG 5,138,451$133,599,0001.53%
Rhenman & Partners Asset Management AB 592,225$15,398,0001.26%
PLATINUM INVESTMENT MANAGEMENT LTD 1,562,869$40,635,0000.93%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 31,434$817,0000.62%
WASATCH ADVISORS LP 3,998,010$103,949,0000.51%
HAMILTON LANE ADVISORS LLC 46,181$1,201,0000.45%
Boxer Capital, LLC 500,000$13,000,0000.42%
DCF Advisers, LLC 38,500$1,001,0000.41%
View complete list of ESPERION THERAPEUTICS INC NE shareholders